Neoplasms Clinical Trials in Philadelphia, Pennsylvania

6 studies are recruiting for neoplasms in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

    This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least o…

    Stage
    Phase 2
    Ages
    Any age
    Site
    University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania
    Locations
    222 in total
    Run by
    Celgene
  2. A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

    The purpose of this study is to characterize safety and to determine the Recommended Phase 2 Dose (RP2D[s]) and optimal dosing schedule(s) of JNJ-88549968 in part 1 (Dose Escalation); to characterize the safety of JNJ- 88549968 at RP2D(s) in part 2 (Cohort Expansion). For U.S. sites: the purpose of…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Pennsylvania, Philadelphia, Pennsylvania
    Locations
    41 in total
    Run by
    Janssen Research & Development, LLC
  3. A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

    The purpose of this study is to determine the safety, feasibility, recommended dose(s) and regimen(s) of JNJ-87704916 as monotherapy and in combination with cetrelimab.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Fox Chase Cancer Center, Philadelphia, Pennsylvania
    Locations
    10 in total
    Run by
    Johnson & Johnson Enterprise Innovation Inc.
  4. A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

    The main purpose of the master is to help the research sites and sponsor carry out several clinical trials more efficiently by providing a common research protocol. Individual clinical trials under this master protocol define drug/disease-specific research goals and activities to test them. New stu…

    Stage
    Phase 2
    Ages
    1 to 39
    Site
    Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
    Locations
    72 in total
    Run by
    Eli Lilly and Company
  5. First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

    The purpose of this study is to investigate a new drug GSK5533524 in adults with certain advanced cancers to find a safe dose and learn how well people tolerate it, so researchers can choose the best dose for the next stage of testing. The study will also check whether the drug can shrink tumours o…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    GSK Investigational Site, Philadelphia, Pennsylvania
    Locations
    16 in total
    Run by
    GlaxoSmithKline
  6. RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

    The RSSearch® Registry is an international multi-year database designed to track SRS/SBRT (Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy) utilization, treatment practices and outcomes to help determine, over time, the most effective use of these systems in management of patients wit…

    Stage
    Not phased
    Ages
    Any age
    Site
    Philadelphia CyberKnife, Philadelphia, Pennsylvania
    Locations
    13 in total
    Run by
    The Radiosurgery Society

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.